Merck (NYSE: MRK) reported sales of $16 billion for the third quarter of 2023, up 7% from the same period a year ago.
GAAP net income increased 46% to $4.7 billion, or $1.86 per share, compared to last year. Adjusted EPS rose 15% to $2.13.
For the full year of 2023, the company expects worldwide sales to be $59.7-60.2 billion and adjusted EPS to be $1.33-1.38.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Key metrics from Citigroup’s (C) Q4 2025 earnings results
Citigroup Inc. (NYSE: C) reported its fourth quarter 2025 earnings results today. Revenues increased 2% year-over-year to $19.9 billion, driven by growth in Banking, Services, US Personal Banking (USPB) and
INFY Earnings: Infosys Q3 FY26 revenues rise 3%; guides FY26
Tech giant Infosys (NYSE: INFY) reported higher revenues for the third quarter of fiscal 2026. The company also issued guidance for the full fiscal year. Third-quarter revenues increased to $5.1
Bank of America reports higher Q4 revenue and profit; results beat estimates
Bank of America Corporation (NYSE: BAC) on Wednesday announced financial results for the fourth quarter of fiscal 2025, with strong revenue and earnings growth. The numbers also came in above
